Rational development of prophylactic HIV vaccines based on structural and regulatory proteins

By Mooij P.   Heeney J.L.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 304-321

Elsevier

Access to resources Recommend Favorite

Quality control of inactivated erysipelas vaccines: results of an international collaborative study to establish a new regulatory test

By Rosskopf-Streicher U.   Johannes S.   Wilhelm M.   Cussler K.  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1477-1483

Elsevier

Access to resources Recommend Favorite

Dendritic cell KLH loading requirements for efficient CD4 + T-cell priming and help to peptide-specific cytotoxic T-cell response, in view of potential use in cancer vaccines

By Millard A.L.   Ittelet D.   Schooneman F.   Bernard J.  

Vaccine, Vol. 21, Iss. 9, 2003-02 ,pp. : 869-876

Elsevier

Access to resources Recommend Favorite

Cancer vaccines

By Moingeon P.  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1305-1326

Elsevier

Access to resources Recommend Favorite

Stabilization of vaccines: to be or not to be

By Arya S.C.  

Vaccine, Vol. 19, Iss. 4, 2000-10 ,pp. : 595-597

Elsevier

Access to resources Recommend Favorite